Patents by Inventor Ulla Ribel-Madsen

Ulla Ribel-Madsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7615532
    Abstract: The present invention relates to insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the ?-amino group of the N-terminal amino acid residue of the B chain or to the ?-amino group of a Lys residue present in the B chain of the parent insulin, the side chain being of the general formula: -W-X—Y-Z wherein W, X, Y and Z are as defined in the disclosure.
    Type: Grant
    Filed: January 30, 2006
    Date of Patent: November 10, 2009
    Assignee: Novo Nordisk A/S
    Inventors: Ib Jonassen, Thomas Hoeg-Jensen, Svend Havelund, Ulla Ribel-Madsen, Tina Møller Tagmose, Peter Madsen
  • Publication number: 20090239784
    Abstract: The present invention relates to human insulin analogues having a fast onset of action. These analogues may have amino acid in position B26 substituted with Phe, or be Des(B30) analogues of human insulin. The invention also relates to compositions comprising such insulin analogues, and to compositions comprising a mixture of an insulin analogue having a fast onset of action and insulin having a protracted action.
    Type: Application
    Filed: June 2, 2009
    Publication date: September 24, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Ib Jonassen, Sven Havelund, Thomas Borglund Kjeldsen, Ulla Ribel-Madsen
  • Publication number: 20090074882
    Abstract: The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin.
    Type: Application
    Filed: December 21, 2006
    Publication date: March 19, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Svend Havelund, Frantisek Hubalek, Helle Birk Olsen, Ib Jonassen, Thomas Hoeg-Jensen, Anne Plum, Ulla Ribel-Madsen
  • Publication number: 20060183668
    Abstract: The present invention relates to insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the ?-amino group of the N-terminal amino acid residue of the B chain or to the ?-amino group of a Lys residue present in the B chain of the parent insulin, the side chain being of the general formula: -W-X-Y-Z wherein W, X, Y and Z are as defined in the disclosure.
    Type: Application
    Filed: January 30, 2006
    Publication date: August 17, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Ib Jonassen, Thomas Hoeg-Jensen, Svend Havelund, Ulla Ribel-Madsen, Tina Tagmose, Peter Madsen
  • Publication number: 20060183667
    Abstract: The present invention relates to human insulin analogues having a fast onset of action. These analogues may have amino acid in position B26 substituted with Phe, or be Des(B30) analogues of human insulin. The invention also relates to compositions comprising such insulin analogues, and to compositions comprising a mixture of an insulin analogue having a fast onset of action and insulin having a protracted action.
    Type: Application
    Filed: January 10, 2006
    Publication date: August 17, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Ib Jonassen, Sven Havelund, Thomas Kjeldsen, Ulla Ribel-Madsen
  • Publication number: 20020165148
    Abstract: The present invention relates to analogues and derivatives of GRP which have a protracted profile of action, as well as their use in treatment of e.g. Type 2 diabetes and obesity.
    Type: Application
    Filed: November 16, 2001
    Publication date: November 7, 2002
    Inventors: Per Franklin Nielsen, Ulla Ribel-Madsen, Peter Andreas Nicolai Reumert Wagtmann